Self-Splicing RNA Platform Encodes Twin PROTACs for Dual-E3 Ligase Recruitment and Programmable Protein Degradation
Journal of the American Chemical Society · 2026
DOI: 10.1021/jacs.6c11759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, 2026. Verfasst von Jiani Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Optic-Electric Sensing and Analytical Chemistry for Life Science, MOE, State Key Laboratory of Advanced Optical Polymer and Manufac…. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Taishan Scholar Project of Shandong Province.
Abstract (Originalsprache)
Proteolysis-targeting chimeras (PROTACs) offer a powerful strategy for targeted protein degradation but are frequently constrained by synthetic complexity and overreliance on a single-E3 ligase, leading to diminished efficacy in tumors with low or heterogeneous ligase expression. Here, we report a genetically encoded artificial self-splicing RNA (asRNA) platform that autonomously generates twin PROTAC effectors from a single transcript, enabling the coordinated recruitment of two distinct E3 ligases. Following transcription, the asRNA undergoes precise ribozyme-mediated self-cleavage to produce a peptide-based PROTAC that recruits the VHL ligase and an RNA aptamer-based PROTAC that engages the Dzip3 ligase, thereby activating complementary ubiquitination pathways. This dual-ligase architecture markedly enhances degradation of otherwise refractory oncogenic targets, including c-MYC and EGFR, resulting in pronounced antitumor efficacy in cancer models. The modular and programmable genetic design enables rapid reconfiguration of target-recognition elements without complex chemical synthesis. As the first single-transcript system to achieve coordinated dual-E3 ligase recruitment, this work establishes a new genetically encoded strategy for multivalent protein degradation and expands the scope of targets accessible to PROTAC-based strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Optic-Electric Sensing and Analytical Chemistry for Life Science, MOE, State Key Laboratory of Advanced Optical Polymer and Manufacturing Technology, College of Chemistry and Molecular Engineering, Qin…
- State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha410082, China.
ORCID-Profile: Zhi-Ling Song, Xiliang Luo, Xiao-Bing Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Taishan Scholar Project of Shandong Province
- National Key Research and Development Program of China
- Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
Zitieren
APA
Ding, J., Wang, S., Tang, Z., Li, Y., Zhang, P., Song, Z. L., Luo, X., & Zhang, X. B. (2026). Self-Splicing RNA Platform Encodes Twin PROTACs for Dual-E3 Ligase Recruitment and Programmable Protein Degradation. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.6c11759
Vancouver
Ding J, Wang S, Tang Z, Li Y, Zhang P, Song ZL, et al. Self-Splicing RNA Platform Encodes Twin PROTACs for Dual-E3 Ligase Recruitment and Programmable Protein Degradation. Journal of the American Chemical Society. 2026. doi:10.1021/jacs.6c11759
BibTeX
@article{Ding2026,
author = {Ding, Jiani and Wang, Shumin and Tang, Zijie and Li, Yao and Zhang, Peisen and Song, Zhi-Ling and Luo, Xiliang and Zhang, Xiao-Bing},
title = {Self-Splicing RNA Platform Encodes Twin PROTACs for Dual-E3 Ligase Recruitment and Programmable Protein Degradation},
journal = {Journal of the American Chemical Society},
year = {2026},
doi = {10.1021/jacs.6c11759}
}
EUVIMED